Establishment Labs Inc. (ESTA)
Bid | 35 |
Market Cap | 1.13B |
Revenue (ttm) | 170.24M |
Net Income (ttm) | -89.1M |
EPS (ttm) | -3.12 |
PE Ratio (ttm) | -12.48 |
Forward PE | -37.63 |
Analyst | Buy |
Ask | 40 |
Volume | 255,122 |
Avg. Volume (20D) | 503,792 |
Open | 37.94 |
Previous Close | 37.44 |
Day's Range | 37.08 - 38.97 |
52-Week Range | 26.56 - 52.41 |
Beta | 0.75 |
About ESTA
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for ESTA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
2 weeks ago · businesswire.com
Establishment Labs to Present at Jefferies Global Healthcare ConferenceNEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...

1 month ago · seekingalpha.com
Establishment Labs Holdings, Inc. (ESTA) Q1 2025 Earnings Call TranscriptEstablishment Labs Holdings, Inc. (NASDAQ:ESTA ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Peter Caldini - Chief Executive Officer Rajbir Denhoy - Chief Financial Of...

1 month ago · businesswire.com
Establishment Labs Appoints Peter Caldini as Chief Executive OfficerNEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...